Tandem Diabetes Care Announces Upcoming Conference Presentations

Rhea-AI Summary

Tandem Diabetes Care (TNDM), a leading insulin delivery and diabetes technology company, has announced its participation in four major healthcare investor conferences in March 2025:

• TD Cowen 45th Annual Health Care Conference - March 4, 2025, 1:50pm ET
• Barclays 27th Annual Global Healthcare Conference - March 11, 2025, 1:30pm ET
• Leerink Partners 2025 Global Healthcare Conference - March 12, 2025, 9:20am ET
• Oppenheimer 35th Annual Healthcare MedTech & Services Conference - March 20, 2025, 12:40pm ET

Management will present company updates at each conference. All presentations will be available via live webcast and archived for 30 days on Tandem's Investor Center website under the 'Events & Presentations' section.

SAN DIEGO--(BUSINESS WIRE)-- Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced that management will present a company update at the following investor conferences:

• TD Cowen 45^th Annual Health Care Conference on Tuesday, March 4, 2025 at 1:50pm Eastern Time (10:50am Pacific Time),
• Barclays 27^th Annual Global Healthcare Conference on Tuesday, March 11, 2025 at 1:30pm Eastern Time (10:30am Pacific Time),
• Leerink Partners 2025 Global Healthcare Conference on Wednesday, March 12, 2025 at 9:20am Eastern Time (6:20am Pacific Time), and
• Oppenheimer 35^th Annual Healthcare MedTech & Services Conference on Thursday, March 20, 2025 at 12:40pm Eastern Time (9:40am Pacific Time).

The presentations will be webcast live, and an archive recording will be available for 30 days. The link to the live webcasts and archive will be accessible on Tandem Diabetes Care’s Investor Center website located at http://investor.tandemdiabetes.com in the “Events & Presentations” section.

About Tandem Diabetes Care, Inc.

Tandem Diabetes Care, a global insulin delivery and diabetes technology company, manufactures and sells advanced automated insulin delivery systems that reduce the burden of diabetes management, while creating new possibilities for patients, their loved ones, and healthcare providers. The Company’s pump portfolio features the Tandem Mobi system and the t:slim X2 insulin pump, both of which feature Control-IQ advanced hybrid closed-loop technology. Tandem Diabetes Care is based in San Diego, California. For more information, visit tandemdiabetes.com.

Tandem Diabetes Care, the Tandem logo, Control-IQ, Tandem Mobi and t:slim X2 are either registered trademarks or trademarks of Tandem Diabetes Care, Inc. in the United States and/or other countries.

View source version on businesswire.com: https://www.businesswire.com/news/home/20250213135679/en/

Media Contact:

858-366-6900

media@tandemdiabetes.com

Investor Contact:

858-366-6900

IR@tandemdiabetes.com

Source: Tandem Diabetes Care, Inc.

FAQ

When is Tandem Diabetes Care (TNDM) presenting at the TD Cowen Healthcare Conference in 2025?

Tandem Diabetes Care will present at the TD Cowen Healthcare Conference on March 4, 2025, at 1:50pm Eastern Time.

How long will TNDM's March 2025 conference presentation webcasts be available?

The webcasts of all conference presentations will be archived and available for 30 days after the live events.

Where can investors access TNDM's March 2025 conference presentation webcasts?

Investors can access the live webcasts and archives through Tandem Diabetes Care's Investor Center website at investor.tandemdiabetes.com in the 'Events & Presentations' section.

Which healthcare conferences will TNDM present at in March 2025?

TNDM will present at four conferences: TD Cowen Annual Health Care Conference, Barclays Global Healthcare Conference, Leerink Partners Global Healthcare Conference, and Oppenheimer Healthcare MedTech & Services Conference.